The Perils of Confidentiality Agreements
The tidal wave of corporate scandals reminds us that the most popular and perhaps viable response for the corporation under siege remains cooperation with government investigators. Reports of disclosure of internal company investigations and documents have come pouring out of Enron, WorldCom, Global Crossing and many others. When corporations divulge potentially privileged materials to the government, concerns about whether such disclosure results in the waiver of the company's attorney-client privilege and the loss of its work product protection inevitably follow.
Criminal Antitrust Violations: Current Limits
The two federal statutes that create criminal liability for antitrust violations are arguably the broadest and most poorly defined of all federal criminal statutes, even recognizing the tortured draftsmanship of the RICO statute and the securities laws' criminal provisions.
To Disclose or Not to Disclose
Recent corporate accounting scandals have brought to light disturbing revelations concerning the business practices of many American companies. New — and more severe — penalties for corporate fraud in the Sarbanes-Oxley Act of 2002 have caused companies to step up their internal efforts to detect and prevent wrongdoing.
How to Extinguish a Lessee's Possessory Interest
The ability of a trustee to sell bankruptcy estate assets free and clear of competing interests in the property has long been recognized as one of the most important advantages of a bankruptcy filing as a vehicle for restructuring a debtor's balance sheet and generating value. Still, section 363(f) of the Bankruptcy Code, which delineates the circumstances under which an asset can be sold free and clear of 'any interest in such property,' has generated a fair amount of controversy. This is so because the statute itself does not define 'interest.'
Insurance Assurance
The insurance market is undergoing turmoil as a result of recent trends, including terrorism, corporate scandals and skyrocketing healthcare costs. Premiums are soaring, causing firms to cut back on coverage or to cut into their profits ' choices that could have a profoundly adverse impact on the firm's future success.
Aggregate Limits: Addressing Arguments Advanced by Policyholders in Asbestos Claims
Now entering its third decade, asbestos exposures threaten the financial stability of numerous commercial entities. Asbestos manufacturers, distributors and installers have been forced to declare bankruptcy because of these exposures. RAND Institute for Civil Justice, "Asbestos Litigation in the U.S.A.: A New Look at an Old Issue" (Aug. 2001). Even companies with only a peripheral connection to asbestos — <i>eg</i>, car manufacturers that used asbestos-lined brakes — have been sued. Asbestos claimants continue to aggressively pursue any entity that had any involvement with asbestos. Indeed, the backlog of asbestos suits in the federal and state courts doubled from about 100,000 in 1990 to 200,000 in 1999. Asbestos Compensation Act of 2000, H.R. Rep. No. 106-782, at 18 (2000). Quite simply, absent federal legislative relief, asbestos cases will continue to clog U.S. courts. Moreover, asbestos litigation has and will continue to bog down a large segment of the U.S. economy. Studies are now projecting that asbestos lawsuits will continue until at least 2030.
Managing E-commerce Partnerships
Q: What do you risk getting when you mix commerce with the Internet?<br>A: A host of possible legal issues.<BR>Proper planning, however, will reduce the legal risk associated with e-commerce pacts and make for a less bumpy ride should the partners decide down the road that they want to go their separate ways.
Five Deadly Sins: Lease Clauses a Landlord Should Refuse to Negotiate Under Any Circumstances
When a landlord or its attorney prepares an initial draft of a lease on the landlord's form, it is expected that the tenant will simply sign the lease (but only if the tenant believes it has no leverage whatsoever), return the lease with handwritten comments, or, if the tenant's comments are extensive and it has taken control of the drafting process, return a black-lined copy of the lease that it has revised.
The Value of 'Research Tool' Patents in View of <i>Integra v. Merck</i>
On June 6, 2003, the Court of Appeals for the Federal Circuit seemingly breathed new life into research tool patents when it held that the use of patented peptides for drug discovery was not exempt from infringement under the "safe harbor" provision of 35 U.S.C. '271(e)(1). <i>Integra Lifesciences, Ltd. v. Merck KGaA,</i> 331 F.3d 860 (Fed. Cir. 2003). In an earlier case, <i>Bristol-Myers Squibb Co. v. Rhone-Poulenc Rorer, Inc.,</i> No. 95 Civ. 8833, 2001 WL 1512597 (S.D.N.Y 2001), a district court had ruled that the use of patented intermediates for drug screening was non-infringing, thereby implicating that the use of other research tool patents for drug discovery was likewise sheltered from infringement liability under '271(e)(1).
